| # | Drug | Count |
|---|---|---|
| 0 | VALSARTAN | 55 |
| 1 | PREDNISONE | 54 |
| 2 | VALSARTAN ORAL | 52 |
| 3 | CICLESONIDE | 51 |
| 4 | IPRATROPIUM BROMIDE | 51 |
| 5 | PAROXETINE HYDROCHLORIDE | 50 |
| 6 | MONTELUKAST SODIUM | 49 |
| 7 | THEOPHYLLINE ANHYDROUS | 49 |
| 8 | DULOXETINE | 46 |
| 9 | DULOXETINE HYDROCHLORIDE | 46 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AMLODIPINE BESYLATE VALSARTAN HYDROCHLOROTHIAZIDE | 1 | 0.0244 |
| 1 | BUPROPION HYDROBROMIDE | 13 | 0.0225 |
| 2 | ANTIHEMOPHILIC FACTOR (RECOMBINANT), PORCINE SEQUENCE | 1 | 0.0065 |
| 3 | GLYCOPYRROLATE | 26 | 0.0046 |
| 4 | FIBRINOGEN HUMAN | 1 | 0.0043 |
| 5 | SODIUM CARBONATE | 1 | 0.0043 |
| 6 | THEOPHYLLINE ANHYDROUS | 49 | 0.0039 |
| 7 | CICLESONIDE | 51 | 0.0037 |
| 8 | NAFCILLIN SODIUM | 3 | 0.0033 |
| 9 | CEFTOLOZANE AND TAZOBACTAM | 3 | 0.0031 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 90 |
| 1 | Angiotensin 2 Receptor Blocker [EPC] | 57 |
| 2 | Proton Pump Inhibitor [EPC] | 52 |
| 3 | Methylxanthine [EPC] | 50 |
| 4 | Provitamin D2 Compound [EPC] | 46 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 45 |
| 6 | Estrogen [EPC] | 32 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 32 |
| 8 | Loop Diuretic [EPC] | 28 |
| 9 | Factor Xa Inhibitor [EPC] | 27 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Provitamin D2 Compound [EPC] | 46 | 0.0015 |
| 1 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 2 | Human Blood Coagulation Factor [EPC] | 1 | 0.0012 |
| 3 | Methylxanthine [EPC] | 50 | 0.0009 |
| 4 | Echinocandin Antifungal [EPC] | 6 | 0.0007 |
| 5 | Anti-coagulant [EPC] | 2 | 0.0005 |
| 6 | Leukotriene Receptor Antagonist [EPC] | 15 | 0.0005 |
| 7 | Actinomycin [EPC] | 1 | 0.0005 |
| 8 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 2 | 0.0003 |
| 9 | Tetracycline-class Antibacterial [EPC] | 2 | 0.0003 |